Journal
HUMAN VACCINES & IMMUNOTHERAPEUTICS
Volume 15, Issue 10, Pages 2337-2342Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/21645515.2019.1621149
Keywords
West Nile virus; vaccines; flavivirus; antibodies
Categories
Ask authors/readers for more resources
West Nile virus (WNV) is a widely spread human pathogenic arthropod-borne virus. It can lead to severe, sometimes fatal, neurological disease. Over the last two decades, several vaccine candidates for the protection of humans from WNV have been developed. Some technologies were transferred into clinical testing, but these approaches have not yet led to a licensed product. This review summarizes the current status of a human WNV vaccine and discusses reasons for the lack of clinically advanced product candidates. It also discusses the problem of immunological cross-reactivity between flaviviruses and how it can be addressed during vaccine development.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available